A common polymorphism in the human gene for catechol-O-methyltransferase results in replacement of Val 108 by Met in the soluble form of the protein (sCOMT), and has been linked to breast cancer and neuropsychiatric disorders. The 108M and 108V variants are reported to differ in their thermal stability, with 108M COMT losing catalytic activity more rapidly. Because human sCOMT contains seven cysteine residues and includes CXXC and CXXS motifs that are associated with thiol-disulfide redox reactions, we examined the effects of reducing and oxidizing conditions on the enzyme. In the absence of a reductant 108M sCOMT lost activity more rapidly than 108V, whereas in the presence of 4 mM dithiothreitol (DTT) we found no significant differences in the stability of the two variants at 37 C. DTT also restored most of the activity that was lost upon incubation at 37 C in the absence of DTT. Mass spectrometry showed that cysteines 188 and 191 formed an intramolecular disulfide bond when sCOMT was incubated with oxidized glutathione, while cysteines 69, 95, 157 and 173 formed protein-glutathione adducts (PSSG). Replacing C95 by serine protected 108M sCOMT against inactivation in the absence of a reductant; C33S and C188 mutations had little effect, and C69S was destabilizing. The sequences surrounding the reactive cysteine residues of human sCOMT and other proteins that form glutathione adducts at identified sites all include Pro and/or Gly and most include a hydrogen-bonding residue, suggesting that glutathiolation at conserved sites plays a physiologically important role. The enzyme catechol-O-methyltransferase (COMT, E.C. 2.1.1.6) modifies a variety of endogenous and exogenous catechol substrates by transferring a methyl group from Sadenosylmethionine (SAM) 1 to either the meta or the para hydroxyl group of the catechol ring. It plays important roles in the metabolism of catechol estrogens and the degradation of the catecholamine neurotransmitters dopamine and epinephrine.
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linked to decreased responses of the m-opioid system to pain (35) . A haplotype that combines the 108/158V allele with particular SNPs in two non-coding regions of the gene is strongly associated with schizophrenia (36) , possibly because it results in decreased expression of the protein (37) . The association of the 108/158M allele with mental dysfunction is particularly strong in patients with velocardiofacial syndrome, who lack the gene for COMT entirely on one copy of chromosome 22 and thus may be especially sensitive to the allele on the other copy (8, 38) .
No high-resolution structures of human COMT have been described. However, crystal structures of rat s-COMT in complex with SAM and catechol inhibitors are known (39) (40) (41) , and the human protein probably is similar in structure because the amino acid sequences are 81% identical (see Figs. 1 and 2 ). The central structural motif, a seven-stranded b-sheet with helices on either side, is also characteristic of other SAMdependent methyltransferases (42) . The SAM-binding domain of human histamine methyltransferase, for example, is superposable on rat s-COMT with an RMS deviation of 2.9 Å over 156 C-a atoms (42) . The variable residue 108 of s-COMT is located in a loop between a helix and b-strand whose distal ends are close to the SAM-binding site (Fig. 1) . The rat protein has a leucine residue at position 108 and no known polymorphism at that location. Remarkably, however, histamine-N-methyltransferase has a common SNP (105Thr/Ile) at almost exactly the same position. In that case, the two variants of the enzyme have somewhat different kinetic properties but similar thermal stabilities (43) .
There has been little discussion of structural differences that might explain the different stabilities or activities of the 108V and 108M variants of human s-COMT.
Whether the inactivation of the 108M enzyme reflects gross unfolding or a more subtle change in the structure is unknown. Weinshilboum and coworkers (17, 19) examined the proteins by polyacrylamide gel electrophoresis, isoelectric focusing, immune fixation, and photoaffinity labeling, and found no significant differences between the Met and Val variants. However, a possible clue comes from early observations that rat s-COMT loses activity on storage but can be reactivated by the reducing agent dithiothreitol (DTT) (44) .
Of the 20 common amino acids, cysteine is the most sensitive to oxidation; the thiol groups of exposed cysteines readily oxidize to form intra-or intermolecular disulfide by guest on September 29, 2016 http://www.jbc.org/ Downloaded from 5 bridges. Cysteine is one of the least abundant amino acids in proteins and also has the highest sequence conservation. Rat s-COMT contains four cysteines (residues 33, 69, 157 and 188), while human s-COMT has seven (33, 69, 95, 157, 173, 188 and 191) . Two of the three additional cysteines in the human protein (C95 and C173) are close to the active site and may contribute to, or modulate substrate binding (see Fig. 1 ). The third (C191) along with C188 forms a CXXC motif, which is found in thioredoxins, glutaredoxins, DsbA and protein disulfide isomerase, proteins that undergo reversible thiol/disulfide oxidation/reduction reactions (45-48) (see Fig. 2 ). In addition, C69 is part of a CXXS motif that is found in many proteins with thiol/disulfide oxido-reductase activities (49).
Fomenko et al. (49) have suggested that the local secondary structure and hydrogen bonding with the serine hydroxyl group makes cysteines in this motif particularly prone to oxidation. Vilbois et al. (12) have shown that cysteines 33, 69, 95 and 173 of human s-COMT react readily with the thiol reagent 5-iodoacetamide fluorescein and that this treatment inactivates the enzyme. They further showed that SAM and MgCl 2 decrease the reaction with cysteines 69 and 95 and partially protect the enzyme against inactivation by the thiol reagent, suggesting that cysteine 69, 95, or both, are essential for catalytic activity (12) . However, no intramolecular disulfide linkages were detected via mass spectroscopy in those studies.
With the above observations in mind, it occurred to us that the reported differences between the thermal stabilities of the 108V and 108M variants of human s-COMT could reflect differences in susceptibility to oxidation or in the effects of oxidation on catalytic activity. The presence of two redox-associated motifs further suggested that cysteine oxidation and/or glutathiolation might be part of a mechanism for regulating COMT activity or, in the case of glutathiolation, for protecting the protein under conditions of In the present work, we have compared the enzymatic activities of the 108V and 108M human s-COMT variants at physiological temperature in the presence or absence of DTT. Additionally, we have studied the effects of C33S, C69S, C95S and C188S mutations on the enzymatic activity and stability of the 108M and 108V variants of recombinant human s-COMT. We also have looked for changes in the redox states of the cysteine residues when the 108M and 108V enzymes are incubated under oxidizing or reducing conditions, and have examined the reactivation of the oxidized enzymes by DTT. human s-COMT in the Novagen pET22b(+) vector, which contains a carboxy-terminal histidine tag. Starting with the 108V clone, we mutated Thr39 to Ala to agree with the NCBI sequence for human s-COMT (NP_009294.1), and then introduced the V108M mutation followed by C33S, C69S, C95S, and C188S mutations for both the 108V and 108M variants. All the mutations were made using the "QuickChange" site-directed mutagenesis kit (Stratagene). DNA from each strain was sequenced to verify the mutation and ensure that no unintended changes had occurred. Recombinant s-COMT was expressed in Escherichia coli BL21*(DE3) cells (Stratagene). Cell cultures with an absorbance of ~0.65 at 595 nm were induced with 500 mM IPTG and grown for six hours at 37 C. Cultures were centrifuged at 4000 x g for 15 minutes at 4 C, and the pellets were re-suspended and disrupted by sonication (50% duty, 80% power, for 10 minutes) in 100 7 mM Tris-HCl pH 8, 300 mM NaCl, 1 mM EDTA, 10% glycerol (v/v), 5 mM bmercaptoethanol, 5 mM MgCl 2 , and 10 mM PMSF. The cell extract was centrifuged at 12,000 x g for 20 minutes at 4 C to pellet any insoluble material. The resulting supernatant was passed through a filter with 0.22 mm pores (Millipore) and applied to a 4 ml column of Talon Metal Affinity resin (Clontech). Nonspecifically bound proteins were cleared using 30 ml of wash buffer (100 mM Tris-HCl pH 7.5, 200 mM NaCl, 5 mM MgCl 2 , 5 mM b-mercaptoethanol) followed by 30 ml of wash buffer with 7 mM imidazole. COMT then was eluted using two 6-ml volumes of elution buffer (wash buffer plus 100 mM imidazole) and pooled into 6 ml of ice-cold storage buffer (100 mM TrisHCl pH 7.5, 200 mM NaCl, 10% glycerol (v/v), 5 mM DTT, 5 mM MgCl 2 ). This procedure yielded up to 15 mg (~0.6 mmol) of COMT per liter of culture. The concentrated protein was dialyzed overnight at 4 C in 2 L storage buffer and stored at -20 C. To remove DTT and mercaptoethanol, enzyme stocks were thawed, exchanged into buffer lacking a reducing agent (50 mM Tris HCl, pH 7.5, 1.5 mM MgCl 2 ) using "Quick Spin" protein columns (Roche), and returned to -20 C for storage.
EXPERIMENTAL PROCEDURES
Protein concentration was determined by the Bradford assay (51) or, in a few cases, ultraviolet absorbance (52) . The latter gave somewhat lower enzyme concentrations, and thus higher specific activities.
COMT Enzymatic Activity. The assay mixture contained 1 mM recombinant COMT, 50 mM Tris-HCl (pH 7.5), 1.5 mM MgCl 2 and, except where indicated otherwise, 4 mM DTT in a total volume of 250 mL. The reaction was initiated by adding 20 mM dihydroxyacetophenone (K m ~10 mM (53, 54) ) and 200 mM SAM (K m ~50 mM (11)), allowed to proceed for 15 or 30 minutes at either 22 or 37 C, and terminated by the addition of 150 ml of saturated NaCl and 250 ml of ethylacetate and vortexing. After the mixture had separated into aqueous and organic phases, 150 ml of the organic phase was removed for analysis by gas chromatography.
The methylated products (4¢-hydroxy-3¢-methoxyacetophenone and 4¢-methoxy-3¢-hydroxyacetophenone) were separated, as shown in Figure 3 trifluoroacetic acid/50% acetonitrile saturated with a-cyano-4-hydroxycinammic acid) and 1.0 mL of the mixture was spotted onto a stainless steel target and allowed to dry.
Positive-ion spectra were collected in the reflector mode. The mass accuracy of fragment ions was ±1 Da. A standard peptide mixture was used for external calibration.
Immunoblotting. After treatment with oxidized glutathione as described above, Bioinformatics and Homology Modeling. Amino acid sequences were aligned using ClustalW (http://www.ebi.ac.uk/clustalw/). The CYSPRED algorithm (55) was used to predict the oxidation states of cysteine residues in human s-COMT. We used the proteinprotein BLAST (blastp) on the NCBI website (http://www.ncbi.nlm.nih.gov/BLAST) to search the SwissProt database (http://www.us.expasy.org.sprot/) for "short, nearly exact" sequence matches. A homology model of human sCOMT was made by starting with the crystal structure of the rat enzyme (39) , replacing the necessary residues, minimizing the vanderWaals, torsional and electrostatic energies of the modified side chains sequentially (56) , and then minimizing the energy of the entire structure using the ENCAD (57) force field. To study the effects of DTT on the stability of s-COMT, we exchanged 108V and 108M protein stocks into buffer lacking DTT by rapid centrifugation through sizeexclusion columns (see Methods). The buffer-exchange process itself did not affect enzyme activity if the protein was incubated at 22 C with 200 mM SAM and 4 mM DTT for one hour before it was assayed. 108M s-COMT that was freed of reductants and then incubated with DTT and SAM in this way had an activity of 16.6 ± 0.8 mM methylated products per 30 minutes per mM enzyme at 22 C, as compared to 16.5 ± 0.8 in controls that were not submitted to the buffer exchange; the corresponding activities for 108V s-COMT were 16.6 ± 0.8 and 16.5 ± 1.4. The protocol for the incubation preceding the enzyme assay was chosen because 4 mM DTT consistently gave high activities with both the wild-type enzymes and the mutants described below. We included SAM in some experiments because Lotta et al. (11) found that it protects 108M s-COMT against inactivation, but it proved not to be essential.
RESULTS

At
By contrast, when the enzyme was assayed in the absence of DTT, 108M s-COMT displayed significantly lower activity than 108V s-COMT (Fig. 4) . The loss of activity by 108M s-COMT was manifest if the enzyme was assayed immediately after thawing, and incubation for periods up to 60 minutes in the absence of DTT had little or no further effect. However, addition of 4 mM DTT restored the enzymatic activity of 108M s-COMT, so that the activity became identical to that of the 108V enzyme within experimental error. In the presence of DTT, incubation for 60 minutes at 37 C had no significant effect on the activity of either variant of the enzyme (see Fig. 4 ). The 108M isoform thus does not appear to be markedly less stable than 108V s-COMT at 37 C if DTT is present.
Similar results (not shown) were obtained when the enzyme was incubated for 15 minutes at 45 C in the presence or absence of DTT, and then returned to 37 C for assay.
Furthermore, the activity of 108M s-COMT that had been incubated for 15 minutes at 45 C in the absence of DTT could be fully restored by adding DTT after the incubation.
DTT thus not only protects 108M s-COMT from inactivation under these conditions, but can reactivate the inactivated enzyme.
Because cysteine residues often are prone to oxidation, we examined the effects of replacing cysteine 33, 69, 95 or 188 by serine in the 108V and 108M enzymes. Column 2 of Table I shows the activities of all ten variants of the enzyme after incubation for 1 hour at 22 C in buffer containing 4 mM DTT and 200 mM SAM. As stated above, the activities of the 108M and 108V enzymes were essentially identical after this treatment. With the exception of 108M/69S, the activities of all the CysAESer mutants were similar to, or slightly higher than those of the wild-type enzymes.
We also were interested to see whether COMT activity could be restored after longer periods of incubation in the absence of reducing agent. Column 3 of Table I gives the ratio of the activities measured at 37 C in the absence or presence of 4 mM DTT, following incubation for 2.5 hr at 37 C without a reductant. Although the buffer was not exchanged to remove DTT in these experiments, the dilution of the protein stocks into the incubation buffer reduced the DTT concentration to below 100 µM, which would be less than the concentration of dissolved O 2 . The activities of most of the mutant enzymes declined upon incubation under aerobic conditions, but could be restored by the addition of 4 mM DTT. The Cys(95)Ser mutation increased the activity measured in the absence of DTT in both the 108V and 108M variants, whereas the Cys(69)Ser mutation appeared to make both variants more sensitive to oxidation.
To examine the sensitivity of the individual cysteine residues to oxidation, we incubated s-COMT under either reducing or oxidizing conditions (7 mM DTT or 5 mM GSSG), alkylated the thiol groups that remained reduced, digested the protein with trypsin, and identified the tryptic peptides by MALDI-TOF mass spectrometry.
Immunoblotting with an IgG2a mouse monoclonal antibody (see Methods) showed that the 108V and 108M variants of s-COMT both formed glutathione-protein disulfide adducts when the proteins were incubated with 5 mM GSSG, and neither 108V nor 108M s-COMT retained measureable enzymatic activity under these conditions. Again, however, the enzymatic activity could be largely or completely restored by the addition of 4 mM DTT (data not shown). Table II Cys173 was the most sensitive to glutathiolation. Figure 5 shows the regions of the mass spectra representing the peptide comprised of residues 163-184, which includes this cysteine. After incubation with DTT, the alkylated peptide (m/z = 2334.6) gave a strong peak, whereas the peak representing the free peptide (m/z = 2277.6) was barely detectable (Fig. 5A ). After incubation with GSSG, the peaks representing the glutathiolated and alkylated peptides had similar intensities (Fig. 5B) . A miscleaved peptide containing Cys 173 (residues 162-184) displayed the same pattern, giving m/z peaks at 2406, 2463 and 2711 for the free, alkylated and glutathiolated peptides, respectively.
The mass peaks for glutathiolated derivatives of the peptides containing cysteines 69, 95 and 157 also were easily identifiable (Table II) . Cysteine 33, though sufficiently exposed to undergo alkylation under reducing conditions, did not form a detectable PSSG derivative in the presence of 5 mM GSSG.
Cysteines 188 and 191 were both fully alkylated in s-COMT that was incubated with DTT, so that the masses of the peptides containing the two cysteines were approximately 114 Da greater than the masses expected for the free peptides ( Fig. 6A and Table II ).
When the protein was incubated with GSSG, the dominant peak moved to the region expected for the free peptides (Fig. 6B) . Masses predicted for glutathiolated derivatives of cysteine188 or 191, or for a doubly glutathiolated peptide, were not observed.
However, inspection of the mass peaks in Figure 6B showed that the sub-peaks for Results similar to those shown in Table II Although numerous proteins form protein-glutathione adducts under oxidizing conditions, the physiological significance of these adducts has remained unclear (58-61).
The particular cysteine residue that is glutathiolated has been identified in approximately 13 proteins, now including human s-COMT. These proteins are listed in Table III along with the amino acid sequences three residues on either side of the reactive cysteine. In all cases, the sequence includes proline and/or glycine, residues that often serve to induce a loop in the protein fold. Cysteines 173 and 95 are located in such loops in s-COMT (see Fig. 1 ). Hydrogen-bonding residues, especially serine and threonine, also are found in almost all the sequences surrounding the reactive cysteine. The short sequences surrounding the known sites of the reactive cysteines were searched for nearly exact matches in the SwissProt database, and the results are included in Table III . In many cases, the search retrieved other proteins that are known to form PSSG adducts, but for which the reactive cysteine residue has not been identified. The searches also returned some proteins that have not been identified as reacting with glutathione.
DISCUSSION
In spite of numerous clinical studies pointing to correlations of particular COMT genotypes with breast cancer and neuropsychiatric disorders, the structural consequences of replacing Val by Met at position 108 have remained largely unknown. The studies described here indicate that the rapid loss of activity by purified 108M s-COMT at physiological temperature probably does not reflect gross unfolding of the protein, but rather the oxidation of Cys residues to form a disulfide bond or, in the presence of GSSG, a glutathione adduct. The 108M variant evidently either is more susceptible to this oxidation, or suffers a greater loss of enzymatic activity in its oxidized form. In the presence of 4 mM DTT, we found no significant differences between the stabilities of the 108V and 108M variants. Additionally, DTT was able to restore activity to both variants of the enzyme following extended periods at 37 C.
Residue 108 is located in a loop between an a-helix (a5) and a b-sheet (b3) that terminate near the binding site for SAM on the opposite side of s-COMT (see Fig. 1 ).
Cysteine 95 resides at the distal terminus of helix a5. It therefore seems possible that COMT proved to be more resistant to the loss of activity in the absence of reductants, in agreement with the hypothesis suggested above (Table II) The MALDI-TOF spectra show that an intramolecular disulfide bond between cysteines 188 and 191 forms under oxidizing conditions. Although the peak intensities in the spectra must be interpreted cautiously, the C188-C191 disulfide appears to predominate over the dithiol in the presence of GSSG (Fig. 6B) . The disulfide is seen in both the 108V and 108M proteins, and under aerobic conditions in the absence of added reductants or oxidants as well as in solutions containing GSSG. Whether the C188-C191 disulfide bond occurs to a significant extent in vivo remains to be determined. It may be pertinent in this context that the membrane-bound form of COMT (mb-COMT) is localized to the nuclear membrane and the endoplasmic reticulum, where many proteins destined for secretion undergo oxidation in eukaryotic cells (64) . Although the kinetic properties of mb-COMT have been described, there are no reported studies of the thermal stabilities or sensitivity to oxidation of the 158M and 158V variants of mb-COMT.
Mutation of Cys 188 to Ser had little effect on the enzymatic activity or stability of either 108Val or 108Met s-COMT, but also could be of greater importance in mb-COMT.
In addition to cysteines, methionine residues in many proteins are susceptible to oxidation (65, 66) . Met108 is accessible to the solvent in the homology model of human s-COMT (Fig. 1) , and thus could be disposed to oxidation. Oxidation to the sulfoxide, if it occurred, might amplify the putative disruptive effects of a methionine at this position. However, we did not observe any peptide masses indicative of methionine oxidation in the MALDI-TOF spectra.
The physiological significance of the reactions of s-COMT with GSSG also requires further exploration. Recent work on other proteins suggests that glutathiolation may serve to protect proteins temporarily from irreversible damage, or to regulate protein activity during oxidative stress. Protein glutathiolation may play a role in redox signaling, as some PSSG complexes undergo glutaredoxin-dependent deglutathiolation while others do not (58, 61) . As Table III shows, the propensities of particular cysteine residues for glutathiolation depend on the local sequence. All the cysteine residues known to undergo glutathiolation are flanked by one or more of the turn-inducing residues proline and glycine, and almost all the surrounding sequences include Thr, Ser or another hydrogenbonding residue. Although it is not surprising that Cys residues in exposed loops would be most vulnerable to reaction with GSSG, the fact that some of these sequences are highly conserved suggests that glutathiolation is physiologically important for at least some of these proteins. Glutathiolation has been shown to inactivate some of these proteins (67) (68) (69) (70) (71) or to introduce new functions such as phosphatase activity (72).
Fomenko et al. (49) have shown that the CxxS motif is associated with cysteine redox functions in proteins with a variety of overall folds. The CxxS sequence usually is sandwiched between a b-sheet and an a-helix, as is the CGYS sequence that contains C69 in s-COMT. The motif CxxS tends to be strongly conserved in other proteins (49) , and the CGYS motif in s-COMT falls within one of the two sequences that are completely conserved in all the available mammal, amphibian and fish sequences of this protein (see Fig. 2 ). In addition, although the CxxS motif has not previously been related specifically to glutathiolation, C69 was one of the cysteines that we found to react with GSSG. Table III illustrates an approach that may be useful for identifying specific cysteine residues that undergo glutathiolation in other proteins. Protein BLAST searches for nearly exact sequence matches to known glutathione binding sites identified potential sites of glutathiolation in a number of other proteins, including some proteins that have been shown experimentally to form PSSG adducts but where the reactive cysteines have not been identified. 
